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Abstract 
 
Stimulus-responsive nanogels have potential as carriers for drugs targeting the skin. It 
is important to estimate the biocompatibility of such materials with the skin since they are 
directly in contact upon application and may induce irritation or inflammation. In the 
current work, blank (drug-free) polyN-isopropylacrylamide (polyNIPAM), poly(NIPAM 
copolymerized butyl acrylate) [poly(NIPAM-co-BA)], and poly(NIPAM copolymerized 
with 5% w/v acrylic acid) [poly(NIPAM-co-AAc)(5%)] nanogels were dosed onto 
freshly excised full-thickness porcine ear skin and the effects on the expression of 
cyclooxygenase-2 (COX-2) determined ex vivo by Western blotting. Modulated COX-2 
expression was indicative that the material had penetrated the skin and keratinocytes of 
the viable epidermis. The poly(NIPAM-co-BA) nanogel was found to exert a 
proinflammatory response when applied topically, as reflected by 67% higher COX-2 
expression relative to the control treatment (p = 0.0035). The data obtained for the 
poly(NIPAM-co-AAc)(5%) nanogel on the other hand, indicated no significant 
modulation in the expression of COX-2 (p = 0.1578), suggest the particles are compatible 
with skin. This was even the case in the presence of co-administered aqueous citric acid 
solution. Overall the data support the use of the multi-responsive poly(NIPAM-co-
AAc)(5%) nanogel for triggered or controlled topical drug delivery applications.  
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1 Introduction 
 
Definitions of nanomaterials have been proposed by various organizations and 
typically range from 1 - 100 nm dimension (Scientific Committee on Emerging and 
Newly Identified Health Risks, 2010, US Food and Drug Administration (FDA) Center 
for Drug Evaluation and Research, 2012). Even though this scale is generally accepted, it 
is very difficult to clearly define the top end of the range, as there is no scientific 
evidence to qualify the appropriateness of the 100 nm limit, i.e. no data are available to 
indicate that a specific size associated with special properties due to the nanoscale. 
Additionally, FDA has suggested that nanomaterial can also be defined as an engineered 
material or end product that exhibits properties or phenomena, including physical or 
chemical properties or biological effects that are attributable to its dimension(s), even if 
these dimensions fall outside of the nanoscale range, up to one micrometer (US Food and 
Drug Administration (FDA) Center for Drug Evaluation and Research, 2012, US Food 
and Drug Administration, 2010). 
Drug carriers of nanoscale dimensions were first reported in the early 70s and since 
then, they have rapidly evolved in the pharmaceutical field (Otto and M. de Villiers, 
2009). Nanogels are nanometric scale networks of chemically or physically cross-linked 
polymer particles (Guterres et al., 2007, Oh et al., 2009). Depending on the chemical 
nature of the monomers used, nanogels undergo conformational transition in the form of 
volume collapse in response to external stimuli, such as temperature (Hoare and Pelton, 
2004), ionic strength (Neyret and Vincent, 1997) and solvent type (Kaneda and Vincent, 
2004). This stimuli-induced behaviour, of absorbing solvated materials into the particles 
such as drugs under a set of conditions, then releasing them when environmental 
conditions change, can be beneficial in drug delivery (Lopez et al., 2004, Zhang et al., 
2006). Due to their submicron size and multiple-stimuli sensitivity, they have potential to 
improve methods of drug delivery over conventional formulations such as creams or 
ointments. To date, limited work has been published on the use of nanogel particles as 
drug carriers for topical administration, although enhanced penetration of a lipophilic 
sunscreen (Alvarez-Román et al., 2004), methotrexate (MTX) (Singka et al., 2010) and 
caffeine (Abu Samah, 2011) have been reported.   
In the development of any new drug delivery system, especially involving those at the 
nanoscale, it is necessary to characterize potential for adverse events. Recent studies have 
suggested that polyN-isopropylacrylamide (polyNIPAM)-based polymers are 
biocompatible even with exposure for longer durations (up to 96 h) (Naha et al., 2010a, 
Wadajkar et al., 2009). The cellular internalization of nanoparticles has also been 
reported (Naha et al., 2010a), a phenomenon supported by Singka who found reduced 
levels of prostaglandin E2 (PGE2) in skin dosed with MTX-loaded nanogel (Singka et al., 
2010). Additionally, it was reported that some unreacted (residual) monomers could 
possibly remain even after being purified, typically in the range of 10 - 1000 ppm for 
polymers used in cosmetic products (Zondlo, 2002). However, after assessment, the 
Cosmetic Ingredient Review (CIR) Expert Panel considered the reported levels as safe to 
be used in cosmetic formulations. 
The skin plays a critical role as a part of the human body defense mechanism system. 
Beneath the cornified stratum corneum (SC) is the viable epidermis which is composed 
of living cells (keratinocytes) that can exhibit rapid characteristic tissue response to 
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damage and irritation via inflammation, as well as protective and repair processes (e.g. 
wound healing) when the irritants get through. The keratinocytes respond to skin 
irritation and injury by cytokine release and a rapid but transient activation of arachidonic 
acid metabolism along both the cyclooxygenase (COX) and lipoxygenase pathways 
(Marks et al., 1998). COX is the key enzyme that is responsible for the conversion of 
arachidonic acid to prostaglandins. Two main COX isoforms have been identified and are 
recognized as cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). COX-1 and 
COX-2 are involved in the biosynthesis of PGE2, a major prostaglandin involved in 
epidermal homeostasis and repair. COX-1 is thought to be involved in normal skin 
homeostasis, whereas COX-2 is important in various responses involving insults to the 
skin either mechanical or chemical. COX-2 has a short half-life and so the relative levels 
of its expression can be directly related to the level of pro- or anti- inflammatory stimulus 
at a particular time point, given that the cells or skin tissues remain viable. This approach 
has been used in probing the UV-induced inflammation in human keratinocyte (HaCaT) 
cells (Shibata et al., 2010) and by to determine the anti-inflammatory properties of fish 
oil in ex vivo skin (Thomas et al., 2007). 
Exogenous compounds and materials applied to the skin have the potential to be toxic 
or irritant. In this study, we wanted to examine the propensity of blank (drug-free) 
nanogels based on N-isopropylacrylamide (NIPAM) to induce skin inflammation. One of 
the early presenting features in such events is the induction of inflammatory processes. In 
the skin, this involves up-regulation in the biosynthesis of COX-2, which in turn 
catalyses production of the inflammation mediators, prostaglandins. Monitoring the 
modulation of short-lived, inducible COX-2 ex vivo, can provide a predictive model of in 
vivo inflammation (Zulfakar et al., 2010). To the best of our knowledge, there are no 
published reports on the propensity of nanogels to induce inflammatory processes in skin. 
Clearly, if such materials caused adverse skin reactions, it would limit their applicability 
in a clinical setting. The present study was therefore undertaken to investigate potential 
inflammatory side-effects following the topical application of the polyNIPAM-based 
nanogels, and their monomers (Table 1) at the tissue level.  
In the current work, Western blot analysis was carried out to quantify the expression 
of COX-2 in protein extracts from full-thickness ex vivo porcine skin following exposure 
to the nanogels, their corresponding monomers (in view of the potential for residual 
monomer content of the nanogels) and a pH modulator (aqueous citric acid, CA). Two 
nanogels of interest were investigated - poly(NIPAM copolymerized butyl acrylate) 
[poly(NIPAM-co-BA)] and poly(NIPAM copolymerized with 5% w/v acrylic acid) 
[poly(NIPAM-co-AAc)(5%)], as both nanogels were shown to enhance the delivery of 
the loaded permeants across the SC (Singka et al., 2010). 
 
2 Materials and methods  
 
2.1 Materials 
 
AAc (99%), CA anhydrous (99.5%), N,N′-methylenebis-acrylamide (MBA), sodium 
hydroxide (NaOH), Whatman® qualitative filter paper Grade 4, acrylamide/bis-
acrylamide (30% solution v/v), ammonium persulfate (APS, ≥98%), aprotinin (≥98%), 
dithiothreitol (DTT, 1 M in water), ethylene diamine tetraacetic acid (EDTA, 98%), 
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Hanks’ balanced salt buffer (HBSB), leupeptin hydrochloride (≥70%), Monoclonal Anti-
β-Actin antibody produced in mouse (clone AC-74, ascites fluid, A 5316), [4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid] (HEPES, ≥99.5%), 
phenylmethylsulphonyl fluoride (PMSF, ≥99%), phosphate buffer solution (PBS, pH 
7.4), polyoxyethylene-sorbitan monolaurate (Tween® 20), ponceau S and Radio-
Immunoprecipitation Assay (RIPA) Buffer were purchased from Sigma-Aldrich (Poole, 
UK). Cyclooxygenase-2 antibody (COX-2, #4842), anti-rabbit immunoglobulins (IgG) 
horseradish-peroxidase (HRP)-linked antibodies and positive controls for COX-2 (RAW 
264.7 cells lysate, untreated or LPS treated) by Cell Signaling Technology were 
purchased from New England BioLabs Ltd. (Hitchin, UK). Full range Rainbow® 
recombinant protein molecular weight marker (12 - 225 kDa) was purchased from GE 
Healthcare Life Sciences (Little Chalfont, UK) and Bio-Rad protein assay reagent from 
Bio-Rad Laboratories GmbH (Munich, Germany). MXB autoradiography film (blue 
sensitive: 18 × 24 cm²) was obtained from Genetic Research Instrumentation Ltd. 
(Braintree, UK). Marvel original dried skimmed milk was purchased from Chivers 
Ireland Ltd. (Dublin, Ireland). NIPAM (99%), BA (99%), potassium persulfate (KPS, 
99.9%), glass wool, bovine serum albumen (BSA), bromophenol blue (99%, UV-VIS), 
dimethyl sulfoxide (DMSO, 99%), gentamycin sulfate, glycerol (99%), glycine (99%), 
N,N,N',N'-tetramethyl-ethylenediamine (TEMED, 99%), positive control lysate for COX-
2 (Human cells-13 lysate, 250 μg in 0.1 mL), sodium bicarbonate (NaHCO3, 99%), 
sodium chloride (NaCl, 99.9%), sodium dodecyl sulphate (SDS), tris 
(hydroxymethyl)methylamine (Tris base, 99.8%), Thermo Scientific SuperSignal® West 
Dura Extended Duration Substrate, filter paper QL100 (equivalent to Whatman Grade 1), 
nitrocellulose transfer membrane (Whatman Protran® BA85 with pore size of 0.45 μm) 
and all other solvents were of analytical grade or equivalent were obtained from Fisher 
Scientific (Loughborough, UK). Freshly excised porcine ears were obtained from a local 
abattoir and immersed in iced HEPES-buffered Hanks' balanced salt (HBHBS) solution 
upon excision, and used within 3 h of slaughtering. 
 
2.2 Nanogel synthesis 
 
PolyNIPAM nanogel synthesis was carried out by a single-step surfactant-free 
emulsion polymerization reaction. NIPAM, MBA, BA or AAc and de-ionized water (150 
mL) were added together in a beaker as outlined in Table 2, and stirred for ~15 min. The 
mixture was continuously stirred at 300 rpm and immersed in a water bath heated to the 
polymerization temperature of ~70°C. The flask was continuously purged with nitrogen 
gas to maintain anoxic conditions, as oxygen could act as a free-radical scavenger that 
might interfere with the polymerization process. After stabilizing for 30 min at ~70°C, 
polymerization was initiated by the addition of a hot pre-dissolved persulfate initiator 
(made-up beforehand in 100 mL of de-ionized water). The color of the solution turned 
from colorless to sky blue until it reached an ultimate ivory white hue, indicating 
successful polymerization (Lin et al., 2006, Pelton and Chibante, 1986). The reaction was 
allowed to proceed for a further 6 h. Once completed, the crude nanogel suspensions 
were cold-filtered through glass wool and filter paper then subjected to repeated steps of 
centrifugation [50,000 x g, 20°C for 1 h in a temperature-controlled Beckman Coulter 
Avanti® J-25 centrifuge (Beckman Coulter Inc., Fullerton, CA)], decantation and re-
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dispersion in de-ionized water (5 times). After the final centrifugation/decantation step, 
the nanogel pellets were stored in a freezer of -20°C for 1 h, then placed into a 
MicroModulyo 230 freeze-dryer (Thermo Scientific, NY) until completely dry (~48 h). 
The resulting product was then stored at 2 – 4°C until use. The characterizations of the 
product nanogels are described elsewhere (Samah et al., 2010). 
 
2.3 Topical application and preparation of skin lysates 
 
The freshly excised full-thickness porcine skin sections were mounted in glass Franz-
type cells. The receptor compartment filled with temperature-equilibrated (~32°C), 
degassed HBHBS-gentamycin (receptor phase). The receptor phase was made up of 
HBSS (9.7 g), HEPES (6 mg), sodium bicarbonate (0.35 g), and gentamycin sulfate (50 
mg) in 1 L de-ionized water. The HBHBS was used as it was proven able to maintain 
skin viability for 24 h (Bronaugh, 2007), while gentamycin served a role to inhibit or 
minimize bacterial growth in the receptor phase. A micro magnetic stirrer bar was added 
into each Franz cell and the complete assembly was placed on a submersible magnetic 
stirring plate (Variomag, Daytona Beach, FL) set up in a thermostatically controlled 
water bath (Fisher Scientific, Loughborough, UK), maintained at ~37°C (the core 
temperature in vivo), providing a skin surface temperature of ~32°C. Skin samples were 
recovered from the diffusion cells 9 h post-application of the treatments (30 mg, gently 
massaged) and the areas to which the treatments were applied were excised. They were 
then cut into small pieces and homogenized using a Silverson® homogenizer (Silverson 
Machines Ltd., Chesham, UK) in a lysis buffer (RIPA buffer with additional fresh 
protease inhibitors: PMSF, EDTA, aprotinin, and leupeptin) at 2°C. After 15 min 
incubation on ice, samples were centrifuged in the Heraeus Multifuge 3 S-R (33,000 x g, 
4°C for 15 min), twice in Eppendorf® tubes. The supernatants were stored at -20°C. 
 
2.4 Protein estimation 
 
Total protein concentration in the skin lysates was determined using the Bio-Rad 
protein assay kit (modified Lowry method) and a standard curve produced using dilutions 
with a range of 0 - 25 μg mL-1 BSA in de-ionized water. The absorbance was determined 
at 595 nm using a UV spectrophotometer (CECIL Instruments CE2041 series 2000, Cecil 
Instruments, Cambridge, UK). The protein concentration in each diluted sample was 
obtained through extrapolation of the standard BSA curve. All samples and standards 
were prepared in replicates of three (n=3). 
 
2.5 COX-2 denaturation 
 
Skin lysates containing 25 μg of soluble proteins were aliquoted to Eppendorf® tubes 
and diluted in a 1:1 ratio with 2X Laemmli buffer containing 0.1 M DTT. The tubes were 
placed in the heating block at 100°C for 5 min, and the samples were cooled down for 5 
min and mixed gently at room temperature before subjected to centrifugation (Heraeus 
Multifuge 3 S-R, 33,000 x g at 4°C for 1 min). The denatured samples were then used 
straight away. 
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2.6 Western blot 
 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed using a XCell SureLockTM Mini - Cell (Invitrogen Ltd., Paisley, UK) 
powered by a Powerpac 300 power pack (Bio-Rad Laboratories Ltd., Hemel Hempstead, 
UK) following the manufacturer’s guidelines. Samples were resolved on 10% SDS-
PAGE separating gel and 4% SDS-PAGE stacking gel. The samples prepared were 
loaded alongside 2.5 μL of Full range Rainbow® recombinant protein molecular weight 
marker (10 - 250 kDa) and a positive control lysate for COX-2. β-actin served as a 
loading control. Histograms represent the ratio of the protein of interest against β-actin 
and the control is 100%. The method used was described previously (Ouitas and Heard, 
2010). 
 
2.7 Data analysis 
 
The data were analyzed using Excel 2007 (Microsoft Office, Microsoft Corp., 
Redmond, WA) and expressed as a mean ± SD. Statistical analysis was performed with 
InStat® for Macintosh, version 3.00 (GraphPad Software Inc., San Diego, CA). 
Significant differences and comparisons of the means between paired data were made 
using Student’s t-test. For multiple comparisons, a one-way analysis of variance 
(ANOVA) analysis was carried out with Tukey’s post-test to identify statistical 
significances between groups. Confidence interval was 95% where p<0.05 was 
considered to be significant. 
 
3 Results and discussion 
 
In this assay, the samples were defined as pro-inflammatory if the level of COX-2 
expression was significantly greater than the vehicle-treated control, i.e. de-ionized water, 
and anti-inflammatory if lower than the control. COX-2 expression is associated with 
inflammatory cascade, thus, any treatments that increased the COX-2 level would be 
indicative of inflammation in the skin tissue. It would also provide confirmatory evidence 
that the material had penetrated the skin and keratinocytes.  
 
3.1 Poly(NIPAM-co-AAc)(5%) nanogel 
 
The blots obtained for the poly(NIPAM-co-AAc)(5%) nanogel, its monomers 
(NIPAM and AAc), pH modulator (aqueous solution of CA) and control nanogel 
(polyNIPAM) are shown in Figure 1. There was no significant difference between 
treatments in comparison to the skin treated with only vehicle (control) (p = 0.5123). The 
poly(NIPAM-co-AAc)(5%) nanogel caused a slightly higher COX-2 expression by only 
17%, and is considered insignificant (p = 0.1578). This promising result suggests that the 
poly(NIPAM-co-AAc)(5%) nanogel is not pro-inflammatory even in the presence of 
aqueous CA solution (pH modulator). A similar result was exhibited by the polyNIPAM 
(p = 0.1458). The non-inflammatory effect exhibited by the poly(NIPAM-co-AAc)(5%) 
and polyNIPAM nanogels could be possibly due to the absence of any reactive 
constituents which might induce any interactions with skin components. The results 
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obtained can be further supported by one of the recent publications, where polyNIPAM 
nanoparticles were assessed for cytotoxicity effect in a HaCaT cell line which served as a 
dermal model (Naha et al., 2010a). The authors discovered that the particles were 
internalized in the cells and predominantly localized in the lysosomes. However, they did 
not significantly induce cytotoxicity even over a broad concentration range (25 - 1000 μg 
mL ̄1). Based on the data in this study, it can be inferred that the poly(NIPAM-co-
AAc)(5%) nanogel was found not to be pro-inflammatory to the skin.  
 
3.2 Poly(NIPAM-co-BA) nanogel 
 
The densitometric analysis of the resulting bands for COX-2 (Figure 2) demonstrated 
that the poly(NIPAM-co-BA) nanogel is pro-inflammatory. The analysis exhibited a 
marked induction of COX-2 by the nanogel, with COX-2 expression of 67% higher than 
the control, i.e. skin treated with the vehicle alone (p = 0.0035). This was followed by the 
polyNIPAM with COX-2 level of 18% higher than the control (p = 0.1458). Surprisingly, 
the aqueous solution of NIPAM monomer (1%) was found not to be pro-inflammatory, as 
its COX-2 expression level was about the same as the control (p = 0.8905). Much less 
intense expression was observed in the skin treated with the saturated aqueous solution of 
MTX than the skin dosed with other treatment groups. It was confirmed that the COX-2 
level was significantly reduced in the skin treated with MTX by about 63% in 
comparison to the control (p = 0.0060). 
The data therefore indicate that the poly(NIPAM-co-BA) nanogel is pro-
inflammatory. The inflammatory effect demonstrated by the nanogel on the skin tissue 
might be triggered in a similar mechanism as the tissue responding after exposure to an 
injurious agent (Ghanayem et al., 1985). In addition to that, oxidative stress pathway 
might also be responsible for the inflammatory reaction. Several nanomaterials had 
exhibited toxicity both in vitro and in vivo via induction of oxidative stress by free radical 
formation at the particle surface (Naha et al., 2010a). Excessive level of free radicals may 
cause impairment to biological components due to oxidation of lipids, proteins and 
deoxyribonucleic acid (DNA). It was reported that, nanoparticles of poly(amido amine) 
(PAMAM) dendrimers had exhibited toxic and inflammatory-like reactions in cells via 
this pathway (Naha et al., 2010b). 
The observed pro-inflammatory response was unexpected but may be explained by 
several factors, including a hydrophobicity factor. The poly(NIPAM-co-BA) was 
prepared by copolymerizing the NIPAM with the BA co-monomer, which aimed to 
reduce the lower critical solution temperature (LCST) of the resultant copolymer 
compared to the polyNIPAM, by increasing its overall hydrophobicity. Thus, the nanogel 
was more hydrophobic in comparison to the poly(NIPAM-co-AAc)(5%), owing to its 
extra hydrocarbon chain originated from the BA co-monomer (Table 1). In a study 
conducted aimed to investigate cell attachment and detachment control with temperature-
induced alteration of surface properties with grafted polyNIPAM copolymers, it was 
reported that the polymers caused deterioration of cellular metabolic functions at lower 
temperatures, when they were in a hydrophilic state (Tsuda et al., 2004). This condition is 
suggested due to cell- and protein- adhesion behavior of the polymers. Individual 
functional groups have been demonstrated to affect protein adsorption, cellular response 
and cell-biomaterial interactions (Lynch et al., 2005, Lindman et al., 2007). Surfaces 
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displaying methyl groups (-CH3) bound to proteins more firmly in comparison to surfaces 
displaying hydroxyl groups (-OH) (Tengvall et al., 1998). This interaction may trigger 
immune response, as shown in another independent study, where the methyl groups were 
found to trigger immune response by increasing the adhesion of inflammatory cells 
(Lindblad et al., 1997). In the current study, the BA region of the poly(NIPAM-co-BA) 
possessed methyl groups originating from the butyl hydrocarbon, whereas the 
poly(NIPAM-co-AAc)(5%) possessed carboxyl groups originating from the AAc 
residues. 
Apart from the above factors, the samples obtained for this study were obtained from 
the in vitro experiment with static diffusion cells. A potential disadvantage of the static 
diffusion cells is that accumulation of penetrants may occur both in the skin and receptor 
chambers in comparison to in vivo models with more complex systems (e.g. blood 
clearance and presence of enzyme activities) (Chilcott et al., 2001). Thus, the likelihood 
to produce the observed effect is higher in the in vitro model compared to the in vivo 
model. In that context, the data from our ex vivo set-up may be viewed as a worst case 
scenario. 
Referring to the ex vivo study of the MTX-loaded poly(NIPAM-co-BA) nanogel, it 
was demonstrated that the nanogel was capable of delivering MTX across the epidermis 
in levels that significantly reduced the biosynthesis of PGE2, a key inflammation 
mediator and product of COX-2 enzymes (Singka et al., 2010). Thus the observed 
reduced level of PGE2 was due to the enhanced delivery of MTX, which appeared to 
overwhelm the pro-inflammatory effect produced by the nanogel. 
 
4 Conclusion 
 
Poly(NIPAM-co-AAc)(5%) nanogel provided no modulation in COX-2 expression, 
suggesting it is skin-compatible, hence suitable for multi-responsive poly(NIPAM-co-
AAc)(5%) triggered drug delivery applications. On the other hand, poly(NIPAM-co-BA) 
nanogel was found to significantly induce COX-2 reaction.  
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Legends to Figures 
 
 
Figure 1. Western blotting and densitometric analysis of COX-2 protein expression for 
poly(NIPAM-co-AAc)(5%). Porcine full-thickness skin was treated for 9 h with the 
following - control (de-ionized water); NIPAM monomer (1% w/v); AAc monomer 
(0.05% v/v); aqueous solution of CA (5% w/v); polyNIPAM; poly(NIPAM-co-
AAc)(5%); poly(NIPAM-co-AAc)(5%) followed by CA solution; and MTX – negative 
control. Results were normalized using β-actin and level in control was arbitrarily 
assigned a value of 100%, (n=3, ± SD). p<0.5123 between treatment groups. 
 
Figure 2. Western blotting and densitometric analysis of COX-2 protein expression for 
poly(NIPAM-co-BA). Porcine full-thickness skin was treated for 9 h with the following - 
control (de-ionized water); NIPAM monomer (1% w/v); polyNIPAM; poly(NIPAM-co-
BA); and MTX (negative control). Results were normalized using β-actin and level in 
control was arbitrarily assigned a value of 100% (n=3, ± SD). * indicates p = 0.8905, vs. 
control; ** indicates p = 0.1458, vs. control; *** indicates p = 0.0035, vs. control and 
**** indicates p = 0.0060, vs. control.  
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Legends to Tables 
 
 
Table 1. Physicochemical properties of NIPAM, AAc and BA monomers (MW – 
molecular weight; cLog P – partition coefficient for n-octanol/water). 
 
 
Table 2. Treatments applied for the protein immunoblot study.  
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